<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[카나리아바이오주주연대 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=48332></link><description><![CDATA[카나리아바이오주주연대 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 15 Apr 2026 10:55:32 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/06/12_3731679047_20250625130357_5737868692.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[OQP BioM Shareholder Alliance: Quest-pharma Tech&#039;s Takeover Bid for OQP BioM Meets Scrutiny Amid Accusations and Silence]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013903</link><description><![CDATA[YONGIN--(Korea Newswire)--OQP BioM Shareholder Alliance (represented by Jung-Woo Bae) has voiced criticism against Dr. Madiyalakan’s refusal to answer official inquiries from the Alliance and his unilateral claims to the media.  A takeover bid for the biotech firm OQP BioM by Quest-pharma Tech (QPT) and its leader, Dr. Madiyalakan, is facing a ㅡmounting storm of controv...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2025/06/31017998_20250627093052_9821134928.jpg]]></url></image><pubDate>Fri, 27 Jun 2025 10:01:51 +0900</pubDate></item></channel></rss>